Dare Bioscience (DARE) Receivables - Other (2017 - 2025)
Dare Bioscience's Receivables - Other came in at $400,000 for Q4 2025, up 73.9% from $229,982 a year earlier and up 8.4% from the prior quarter.
Powered by 
Analysis
Dare Bioscience (DARE) Receivables - Other (2017 - 2025) Analysis & Trends
At the end of FY2025, Dare Bioscience's Receivables - Other was $573,061, up 149.2% from FY2024.
- Receivables - Other carries a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- Going back by year, Receivables - Other was $229,982 in FY2024 (-75.8%), $949,211 in FY2023 (-44.3%), $1.7 million in FY2022 (+48.7%) and $1.15 million in FY2021 (+148.9%).
- The Q4 2025 figure represents the highest quarterly Receivables - Other since Q3 2024.
- Year-over-year, Receivables - Other increased in two of the last eight quarters, with an average decline of 30.1%.
- The fastest year-over-year change in Receivables - Other over five years came in Q1 2022 (growth of 473.1%), and the weakest in Q1 2025 (a decline of 92.4%).
- Business Quant data shows DARE's Receivables - Other at $369,157 (Q3 2025), $188,116 (Q2 2025) and $105,234 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Dare Bioscience | 11.38 Mn | -54.09 Mn | -132,343.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 369,157.00 |
| Jun 30, 2025 | 188,116.00 |
| Mar 31, 2025 | 105,234.00 |
| Dec 31, 2024 | 229,982.00 |
| Sep 30, 2024 | 518,886.00 |
| Jun 30, 2024 | 902,174.00 |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 949,211.00 |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 572,466.00 |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 156,247.00 |
| Jun 30, 2021 | 2.96 Mn |
| Mar 31, 2021 | 301,835.00 |
API Access
Dare Bioscience Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();